Translate

Friday, November 9, 2018

Strides’ unit inks pact with SUDA Pharmaceuticals for migraine drug

Strides Pharma Science’s step-down subsidiary has entered into an exclusive product development, licensing and supply agreement with Australia’s SUDA
Source: BHT